Kailera Therapeutics (NasdaqGS:KLRA) completed its initial public offering, moving from private to public ownership. Alongside the IPO, the company adopted an amended and restated certificate of incorporation and new bylaws that reshape its governance framework. The governance changes include a classified board of directors, authorization of preferred stock, and defined procedures for shareholder actions. Kailera Therapeutics was added to the NASDAQ Composite Index, bringing the stock into a...